Cargando…

Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase

Scalable isogenic models of cancer-associated mutations are critical to studying dysregulated gene function. Nonsynonymous mutations of splicing factors, which typically affect one allele, are common in many cancers, but paradoxically confer growth disadvantage to cell lines, making their generation...

Descripción completa

Detalles Bibliográficos
Autores principales: Boddu, Prajwal C., Gupta, Abhishek K., Kim, Jung-Sik, Neugebauer, Karla M., Waldman, Todd, Pillai, Manoj M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514589/
https://www.ncbi.nlm.nih.gov/pubmed/34645977
http://dx.doi.org/10.1038/s42003-021-02690-1
_version_ 1784583423823708160
author Boddu, Prajwal C.
Gupta, Abhishek K.
Kim, Jung-Sik
Neugebauer, Karla M.
Waldman, Todd
Pillai, Manoj M.
author_facet Boddu, Prajwal C.
Gupta, Abhishek K.
Kim, Jung-Sik
Neugebauer, Karla M.
Waldman, Todd
Pillai, Manoj M.
author_sort Boddu, Prajwal C.
collection PubMed
description Scalable isogenic models of cancer-associated mutations are critical to studying dysregulated gene function. Nonsynonymous mutations of splicing factors, which typically affect one allele, are common in many cancers, but paradoxically confer growth disadvantage to cell lines, making their generation and expansion challenging. Here, we combine AAV-intron trap, CRISPR/Cas9, and inducible Cre-recombinase systems to achieve >90% efficiency to introduce the oncogenic K700E mutation in SF3B1, a splicing factor commonly mutated in multiple cancers. The intron-trap design of AAV vector limits editing to one allele. CRISPR/Cas9-induced double stranded DNA breaks direct homologous recombination to the desired genomic locus. Inducible Cre-recombinase allows for the expansion of cells prior to loxp excision and expression of the mutant allele.  Importantly, AAV or CRISPR/Cas9 alone results in much lower editing efficiency and the edited cells do not expand due to toxicity of SF3B1-K700E. Our approach can be readily adapted to generate scalable isogenic systems where mutant oncogenes confer a growth disadvantage.
format Online
Article
Text
id pubmed-8514589
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85145892021-10-29 Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase Boddu, Prajwal C. Gupta, Abhishek K. Kim, Jung-Sik Neugebauer, Karla M. Waldman, Todd Pillai, Manoj M. Commun Biol Article Scalable isogenic models of cancer-associated mutations are critical to studying dysregulated gene function. Nonsynonymous mutations of splicing factors, which typically affect one allele, are common in many cancers, but paradoxically confer growth disadvantage to cell lines, making their generation and expansion challenging. Here, we combine AAV-intron trap, CRISPR/Cas9, and inducible Cre-recombinase systems to achieve >90% efficiency to introduce the oncogenic K700E mutation in SF3B1, a splicing factor commonly mutated in multiple cancers. The intron-trap design of AAV vector limits editing to one allele. CRISPR/Cas9-induced double stranded DNA breaks direct homologous recombination to the desired genomic locus. Inducible Cre-recombinase allows for the expansion of cells prior to loxp excision and expression of the mutant allele.  Importantly, AAV or CRISPR/Cas9 alone results in much lower editing efficiency and the edited cells do not expand due to toxicity of SF3B1-K700E. Our approach can be readily adapted to generate scalable isogenic systems where mutant oncogenes confer a growth disadvantage. Nature Publishing Group UK 2021-10-13 /pmc/articles/PMC8514589/ /pubmed/34645977 http://dx.doi.org/10.1038/s42003-021-02690-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Boddu, Prajwal C.
Gupta, Abhishek K.
Kim, Jung-Sik
Neugebauer, Karla M.
Waldman, Todd
Pillai, Manoj M.
Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase
title Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase
title_full Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase
title_fullStr Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase
title_full_unstemmed Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase
title_short Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase
title_sort generation of scalable cancer models by combining aav-intron-trap, crispr/cas9, and inducible cre-recombinase
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514589/
https://www.ncbi.nlm.nih.gov/pubmed/34645977
http://dx.doi.org/10.1038/s42003-021-02690-1
work_keys_str_mv AT bodduprajwalc generationofscalablecancermodelsbycombiningaavintrontrapcrisprcas9andinduciblecrerecombinase
AT guptaabhishekk generationofscalablecancermodelsbycombiningaavintrontrapcrisprcas9andinduciblecrerecombinase
AT kimjungsik generationofscalablecancermodelsbycombiningaavintrontrapcrisprcas9andinduciblecrerecombinase
AT neugebauerkarlam generationofscalablecancermodelsbycombiningaavintrontrapcrisprcas9andinduciblecrerecombinase
AT waldmantodd generationofscalablecancermodelsbycombiningaavintrontrapcrisprcas9andinduciblecrerecombinase
AT pillaimanojm generationofscalablecancermodelsbycombiningaavintrontrapcrisprcas9andinduciblecrerecombinase